We present the first results obtained with a detector, called Large Area Pixelized Detector (LAPD), dedicated to the beam ballistic control in the context of hadrontherapy. The purpose is to control the ballistics of the beam delivered to the patient by in-beam and real time detection of secondary particles, emitted during its irradiation. These particles could be high energy photons (prompt γ), or charged particles like protons, or 511 keV γ from the annihilation of a positron issued from the β+ emitters induced in the patient tissues along the beam path. These methods require being able to detect with a huge efficiency, and with a minimum dead time, these secondary particles emitted when the beam hits the patient. The LAPD is similar to a conventional Positron Emission Tomography camera. The 511keV γ are detected and the reconstructed line of responses allow to measure the β+ activity distribution. Nevertheless, when trying to use γ from positron annihilations for the ballistic control in hadrontherapy, the large γ prompt background should be taken into account and properly rejected. This detector is made of two half-rings of 120 channels each. Each channel consists of a 13*13*15 mm3 LYSO crystal glued to a PMT. The PMT signal is sent to an Analog Sampling Module (ASM board). This VME 6U board is based on the DRS4 chip technology (Switch Capacitor Array) from the Paul Sherrer Institute and was specially designed for the LAPD detector. This board receives up to 24 differential analog input signals, with maximum amplitude of 600 mV, digitized by 12 bits - 33 MHz ADC. The sampling rate varies between 1 and 5 GHz, for a maximum buffer size of 1024 samples. The first part of the talk is devoted to the description of the detector and its electronics. Then, we describe the various trigger strategy, and the on-going upgrade of the VME-based acquisition system to a μTCA-based technology. The selection of the coincident 511 keV γ is also discussed, and the reconstruction using an iterative MLEM algorithm is presented. In the last part of the talk, few results from an experiment with one third of the detector, using proton and carbon ion beams at the Heidelberg Ion-Beam Therapy Center in 2014, are also described, and the Coincidence Resolution Time and energy resolution are given. First reconstruction results, obtained with a phantom filled with a high intensity FDG source at the cancer research center of Clermont-Ferrand in 2015 are also shown. This detector is now characterized, and will be installed at the Lacassagne hadrontherapy center (Nice, France), on the 65 MeV line (Medicyc) in December 2015 first, and on the future 230 MeV line (S2C2 from IBA) in 2016. The capability of this detector and its associated electronics to measure the ballistic of the proton beam in real clinical conditions with a sufficient precision will be evaluated.